TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
Sensitivity to Endocrine Therapy Index Predicts Benefit from Weekly Adjuvant Paclitaxel for Hormone Receptor-Positive Breast Cancer in the GEICAM/9906 Trial.
Miguel Martín et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.